Long-term follow-up of early stage HER2-positive breast cancer patients treated with trastuzumab: A population-based real world multicenter cohort study

INTRODUCTION: Since its introduction in standard of care, trastuzumab has revolutionized the treatment of patients with early and late stages of HER2-positive breast cancer. While the initial clinical trials were convincing and lead to major changes in practice, more knowledge on the long-term outco...

Descripción completa

Detalles Bibliográficos
Autores principales: Ellegård, Sander, Engvall, Kristina, Asowed, Mustafa, Hallbeck, Anna-Lotta, Elander, Nils, Stål, Olle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9379250/
https://www.ncbi.nlm.nih.gov/pubmed/35982977
http://dx.doi.org/10.3389/fonc.2022.861324

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9379250/
https://www.ncbi.nlm.nih.gov/pubmed/35982977
http://dx.doi.org/10.3389/fonc.2022.861324

Ejemplares similares